Ranbaxy Laboratories Q2 loss at Rs.585.72 crore for the quarter ended in June, Latest stock price
Ranbaxy Laboratories Ltd has announced the financial results for the quarter ended June 30, 2012.
The Company has posted a net (Loss) of Rs. (9256.66) million for the quarter ended June 30, 2012 as compared to net profit of Rs. 1503.75 million for the quarter ended June 30, 2011. Total Income has increased from Rs. 12983.46 million for the quarter ended June 30, 2011 to Rs. 15869.86 million for the quarter ended June 30, 2012.
The Group has posted consolidated Net (Loss) after tax, minority interest and share in loss of associate of Rs (5857.25) million for the quarter ended June 30, 2012 as compared to Net Profit after tax, minority interest and share in loss of associate of Rs 2432.35 million for the quarter ended June 30, 2011. Total Income has increased from Rs 21303.14 million for the quarter ended June 30, 2011 to Rs 32982.16 million for the quarter ended June 30, 2012.
LATEST STOCK PRICE 
No comments:
Post a Comment